Prevention and management of gastroesophageal varices
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Yeon Seok | - |
dc.date.accessioned | 2021-09-02T14:44:34Z | - |
dc.date.available | 2021-09-02T14:44:34Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77244 | - |
dc.description.abstract | Bleeding from gastroesophageal varices is a serious complication in patients with liver cirrhosis and portal hypertension. Although there has been significance improvement in the prognosis of variceal bleeding with advancement in diagnostic and therapeutic modalities for its management, mortality rate still remains high. Therefore, appropriate prevention and rapid, effective management of bleeding from gastroesophageal varices is very important. Recently, various studies about management of gastoesophageal varices, including prevention of development and aggravation of varices, prevention of first variceal bleeding, management of acute variceal bleeding, and prevention of variceal rebleeding, have been published. The present article reviews published articles and practice guidelines to present the most optimal management of patients with gastroesophageal varices. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC STUDY LIVER | - |
dc.subject | RETROGRADE TRANSVENOUS OBLITERATION | - |
dc.subject | INTRAHEPATIC PORTOSYSTEMIC SHUNT | - |
dc.subject | ENDOSCOPIC INJECTION SCLEROTHERAPY | - |
dc.subject | RANDOMIZED-CONTROLLED-TRIAL | - |
dc.subject | TERM-FOLLOW-UP | - |
dc.subject | PLUS ISOSORBIDE MONONITRATE | - |
dc.subject | NONSELECTIVE BETA-BLOCKERS | - |
dc.subject | BLEEDING GASTRIC VARICES | - |
dc.subject | SMALL ESOPHAGEAL-VARICES | - |
dc.subject | HIGH-RISK PATIENTS | - |
dc.title | Prevention and management of gastroesophageal varices | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Yeon Seok | - |
dc.identifier.doi | 10.3350/cmh.2017.0064 | - |
dc.identifier.scopusid | 2-s2.0-85057246044 | - |
dc.identifier.wosid | 000436329800003 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, v.24, no.1, pp.20 - 42 | - |
dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.title | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 20 | - |
dc.citation.endPage | 42 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002354801 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | RETROGRADE TRANSVENOUS OBLITERATION | - |
dc.subject.keywordPlus | INTRAHEPATIC PORTOSYSTEMIC SHUNT | - |
dc.subject.keywordPlus | ENDOSCOPIC INJECTION SCLEROTHERAPY | - |
dc.subject.keywordPlus | RANDOMIZED-CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | TERM-FOLLOW-UP | - |
dc.subject.keywordPlus | PLUS ISOSORBIDE MONONITRATE | - |
dc.subject.keywordPlus | NONSELECTIVE BETA-BLOCKERS | - |
dc.subject.keywordPlus | BLEEDING GASTRIC VARICES | - |
dc.subject.keywordPlus | SMALL ESOPHAGEAL-VARICES | - |
dc.subject.keywordPlus | HIGH-RISK PATIENTS | - |
dc.subject.keywordAuthor | Cirrhosis | - |
dc.subject.keywordAuthor | Portal hypertension | - |
dc.subject.keywordAuthor | Ligation | - |
dc.subject.keywordAuthor | Obturation | - |
dc.subject.keywordAuthor | Obliteration | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.